Inactive Instrument

Company Lescarden Inc.

Equities

LCAR

US5268671063

Biotechnology & Medical Research

Business Summary

Lescarden Inc. is engaged in the research, testing and development of medications for the control and cure of various diseases, and the licensing of its technologies for commercialization by other companies. The Company's product line is led by Catrix Wound Dressing, a powder derived from bovine cartilage for the management of chronic lesions and burns, and helpful when applied to non-healing wounds, such as decubitus ulcers, venous stasis ulcers and diabetic ulcers. It also offers Catrix-based skin care products targeting the plastic surgery, dermatology and medical spa markets. It sells two nutritional supplements, including Bio-Cartilage and Poly-NAG, a glucosamine polymer. It has also developed a 5% Catrix Rejuvenation Cream and a 5% Catrix Lip Balm. Derived from specially processed crustacean shells, Poly-NAG is a polymeric form of glucosamine (Poly-N-Acetyl-D-Glucosamine) that is marketed by the Company in the anti-arthritic market as a treatment for osteoarthritis.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 63,622,316 63,622,316 ( 100.00 %) 0 100.00 %

Company contact information

Lescarden, Inc.

420 Lexington Avenue Suite 212

10170, New York

+

http://www.catrix.com
address Lescarden Inc.(LCAR)
  1. Stock Market
  2. Equities
  3. LCAR Stock
  4. Company Lescarden Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW